Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2651 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-01-16 (investing.com)
Biogen appoints new Chief Accounting Officer By
Biogen Inc. (NASDAQ: ), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025. The announcement, based on a recent SEC filing, indicates a strategic shift in the company's finance leadership as current Chief Financial Officer Michael McDonnell is set to retire on the same date.
Read more
2025-01-10 (pharmiweb.com)
Biogen Appoints Adam Feire as Head of Business Development and External Innovation -
Biogen Inc. (Nasdaq: BIIB) – today announced the appointment of Adam Feire, Ph.D., as Head of Business Development and External Innovation. Mr. Feire reports to Adam Keeney, Ph.D., Executive Vice President and Head of Corporate Development. In this role, Mr. Feire leads the search and evaluation of external ...
Read more
2024-10-29 (manilatimes.net)
Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer
CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as Chief Medical Officer and Head of Medical Affairs, effective October 28, 2024. Dr. Quirk will report to Priya Singhal, M.D., M.P.H., Head of Development at Biogen.
Read more
2024-09-26 (life-sciences-usa.com)
Organon–Karp D: management, 202409– promoted to EVP Corporate Development before Chief Business Development Officer before Biogen + Pfizer
Life Sciences Business Intelligence Web Portal for North America, Europe and Israel
Read more
2024-09-18 (limerickleader.ie)
Limerick man named new president of Irish Pharmaceutical Healthcare Association
The organisation also launched its General Election Manifesto bringing forward innovative ideas on how patients in Ireland can have faster access to new medici...
Read more
2024-08-09 (prnewswire.com)
Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update
– Jason Tardio, Experienced Multiple Sclerosis Drug Commercialization Executive, Formerly with Novartis and Biogen, Appointed Chief Operating Officer and...
Read more
2024-08-07 (funderlyst.com)
Sofinnova Welcomes Biogen CMO to Investment Team
Dr. Maha Radhakrishnan joins Sofinnova Investments as executive partner. See how her experience will benefit the team! Learn more.
Read more
2024-08-07 (alternativeswatch.com)
Sofinnova names Biogen CMO to investment team
Sofinnova Investments added Dr. Maha Radhakrishnan, former chief medical officer at Biogen, to its investment team as an executive partner.
Read more
2024-07-05 (pfarma.com.br)
Biogen presents new Compliance Director
Lawyer Larissa Ferreira arrives at Biogen to lead the compliance area. The executive has more than 10 years of career leading local departments...
Read more